Price $2.95 |
Market Cap
22.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
18.4
|
P/B
0.98
|
P/S
1.11
|
Dividend %
-
|
|
P/CF
77.0
|
P/FCF
3.6
|
Op. Cash Flow
8.3K
|
FCF
1.0
|
|
Op. Margin
18.40%
|
Net Margin
6.00%
|
ROE
5.50%
|
ROI
4.60%
|
|
ROA
2.00%
|
EPS Growth
171.50%
|
Current Ratio
1.0
|
Debt/Equity
93.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vycor Medical Inc (VYCO) | $0.30 | - | - | 3.8M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.71 | - | - | 4.8M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| iCAD Inc (ICAD) | $3.67 | - | - | 64.7M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.38 | - | - | 17.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
